Inventor · disambiguated record
Adriana Ingrid Velter
Also filed as: VELTER ADRIANA INGRID
9 granted patents·11 pending applications·10 citations·filing 2010–2021
79Inventor score
Files withJANSSEN PHARMACEUTICA NV14BISCHOFF FRANCOIS PAUL1CELLZOME LTD1GIJSEN HENRICUS JACOBUS MARIA1JANSSEN PHARMACEUTICALS INC1
Top patents by PatentIndex Score
20 records- 0174US8987276B2Substituted triazolyl piperazine and triazolyl piperidine derivatives as gamma secretase modulatorsBISCHOFF FRANCOIS PAUL·Filed 2012·Granted Mar 24, 2015·4 cites·12 claims
- 0268US9115143B2Substituted indole derivatives as gamma secretase modulatorsMINNE GARRETT BERLOND·Filed 2012·Granted Aug 25, 2015·3 cites·14 claims
- 0367US9181245B2Substituted pyrido[1,2-a]pyrazines and substituted pyrido[1,2-a][1,4]diazepines for the treatment of (inter alia) Alzheimer's diseaseJANSSEN PHARMACEUTICALS INC·Filed 2013·Granted Nov 10, 2015·1 cites·14 claims
- 0467US8946266B2Substituted triazole and imidazole derivatives as gamma secretase modulatorsWU TONGFEI·Filed 2010·Granted Feb 3, 2015·2 cites·14 claims
- 0553US2024124487A1Branched macrocyclic 4-(pyrazol-5-yl)-indole derivatives as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0652US2023265105A1Macrocyclic 7-pyrazol-5-yl-indole derivatives as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0752US2015094311A1Novel substituted bicyclic heterocyclic compounds as gamma secretase modulatorsCELLZOME LTD·Filed 2014·Application pending·0 cites
- 0851US2023234965A1N-linked macrocyclic 4-(pyrazol-5-yl)-indole derivatives as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0951US2023234969A1N-linked macrocyclic 7-(pyrazol-5-yl)-indole derivatives as inhibiors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1050US2023250109A1Macrocyclic ether containing indole derivatives as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1150US2023058733A1Oga inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 1250US2023099293A1Oga inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 1349US2023130109A1Macrocyclic indole derivatives as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1448US10562897B2Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Feb 18, 2020·0 cites·11 claims
- 1543US8946426B2Substituted bicyclic heterocyclic compounds as gamma secretase modulatorsGIJSEN HENRICUS JACOBUS MARIA·Filed 2010·Granted Feb 3, 2015·0 cites·9 claims
- 1642US10246454B2Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 2, 2019·0 cites·11 claims
- 1742US2021130352A1Oga inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 1842US2021277003A1Oga inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 1940US11319321B2[1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 3, 2022·0 cites·6 claims
- 2036US10947242B2[1,2,4]triazolo[1,5and#8208;A]pyrimidine compounds as PDE2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Mar 16, 2021·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →